CSIMarket
 
Xtant Medical Holdings Inc   (XTNT)
Other Ticker:  
 
 

Xtant Medical Holdings Inc Growth Comparisons

Select each growth Category to receive further Information



XTNT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 27.37 % -12.85 % 2.77 % -1.63 %
Q / Q Revenue Growth (Q2 MRQ) 8.45 % 0.48 % 3.45 % 1.45 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 19.92 % -14.02 % -1.15 % %
Seq. Revenue Growth (for 12 months ending Q2 TTM) 6.64 % -3.32 % -0.68 % -0.5 %
Revenue 5 Year Average Growth -0.47 % 9.14 % 11.18 % 11.39 %


XTNT's Growth Comparisons in II. Quarter 2023




Xtant Medical Holdings Inc showed impressive 27.37% year on year rise in the second quarter 2023 to 19 millions, despite the -12.85% in the Biotechnology & Pharmaceuticals industry, Healthcare sector grew 2.77%. Although Biotechnology & Pharmaceuticals industry's Sales were softer then -1.63% overall market growth, Xtant Medical Holdings Inc and the Healthcare sector have delivered above average market Sales.

Comparing the company's Revenue to the first quarter results, sales were higher by 8.45% . On the yearly basis, average annual sales growth for Xtant Medical Holdings Inc is -0.47%, while S & P 500's including only Businesses with the second quarter 2023 earnings, average annual sales growth is 11.39% over the past five years.


Growth Rates of XTNT's Income in the second quarter 2023


XTNT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - -82.05 % -15.94 % -8.89 %
Seq. Operating Income Change (Q2 MRQ) - -17.83 % -31.42 % -2.13 %
Y / Y Operating Income Growth (Q2 TTM) - -34.24 % -20.75 % -5.95 %
Seq. Operating Income Growth (Q2 TTM) - -18.35 % -11.88 % -3.28 %
Operating Income 5 Year Avg. Change - -14.45 % 6.67 % 11.23 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - - -14.51 % -7.41 %
Seq. Income from Cont. Ops. Change (Q2 MRQ) - - -25.87 % -4.41 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - -23.67 % -44.39 % -7.96 %
Seq. Income from Cont. Ops. Change (Q2 TTM) - -20.97 % -20.13 % -3.1 %
Income from Cont. Ops. 5 Year Avg. Change - 19.39 % 31.74 % 2.69 %

XTNT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - - -14.69 % -5.12 %
Q / Q Net Income Growth (Q2 MRQ) - - -26.98 % -2.52 %
Y / Y Net Income Change (Q2 TTM) - -22.25 % -42.48 % -7.87 %
Seq. Net Income Change (Q2 TTM) - -20.97 % -19.77 % -2.61 %
Net Income 5 Year Avg. Growth - 19.4 % 31.58 % 2.98 %

XTNT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - - -14.51 % -7.41 %
Seq. EPS from Cont. Ops. Change (Q2 MRQ) - - -25.87 % -4.41 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q2 TTM) - 324.73 % - 31192.14 %
EPS from Cont. Ops. 5 Year Avg. Growth - 2.93 % 31.74 % 2.69 %



XTNT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - - -14.69 % -5.12 %
Q / Q EPS Net Growth (Q2 MRQ) - - -26.98 % -2.52 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 21973.49 %
Seq. EPS Net Change (for 12 months ending Q2 TTM) - 209.42 % - 26847.85 %
EPS Net 5 Year Avg. Change - 19.4 % 31.58 % 2.98 %



Xtant Medical Holdings Inc reported bottom-line of $ -0.02 in the second quarter, compare to $ -0.02 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry fell by -12.85%, while Healthcare sector decreased by -14.69%, and overall market declined by -5.12%.

Comparing company's EPS to the first quarter results, income per share were higher by 8.45% . On the yearly basis, average annual income per share growth for Xtant Medical Holdings Inc is -0.47%, while S & P 500's including only the businesses with the second quarter 2023 Results, average annual income per share growth is 2.98% over the past five years.

XTNT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - -44.21 % 4.06 % -20.38 %
Seq. Free Cash Flow Change (Q2 MRQ) - - 43.16 % 103.6 %
Y / Y Free Cash Flow Change (Q2 TTM) - -44.97 % -16.9 % -12.52 %
Seq. Free Cash Flow Change (Q2 TTM) - -14.63 % -3.8 % -8.26 %
Free Cash Flow 5 Year Avg. Change - 2.42 % 22.57 % 24.54 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - 7553.43 % - -
Seq. Net Cash Flow Change (Q2 MRQ) - -83.15 % - -
Y / Y Net Cash Flow Change (Q2 TTM) - - - -
Seq. Net Cash Flow Change (Q2 TTM) - 15.54 % 20.68 % -
Net Cash Flow 5 Year Avg. Change 50.16 % - -0.06 % 51.56 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 26.99 % 1.26 % 8.65 % 14.15 %
Seq. Capital Expenditures Change (Q2 MRQ) -9.21 % 5.89 % 0.56 % 6.62 %
Y / Y Capital Expenditures Change (Q2 TTM) -1.19 % -16.65 % 6.2 % -27.94 %
Seq. Capital Expenditures Change (Q2 TTM) 5.07 % 1.51 % 1.15 % -13.89 %
Capital Expenditures 5 Year Avg. Change - -5.84 % 8.86 % 9.39 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com